Position in GILD
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$316,355
-$18,133 QoQ
Shares Held
2,504
+4.3% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#1,618
of 2,266 holders
Holding Since
Jun 2020
10 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Allen Capital Group, LLC holds $17,687,025 across 8 Drug Manufacturers - General names. GILD ranks #8 (1.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PFE |
Pfizer Inc
|
218,728 | $5,266,970 | |
| 2 | NVO |
Novo Nordisk A S
|
76,530 | $3,668,848 | |
| 3 | JNJ |
Johnson & Johnson
|
12,012 | $3,050,687 | |
| 4 | LLY |
ELI LILLY & Co
|
2,102 | $2,521,202 | |
| 5 | MRK |
Merck & Co., Inc.
|
10,589 | $1,360,686 | |
| 6 | ABBV |
AbbVie Inc.
|
3,915 | $985,170 | |
| 7 | AMGN |
Amgen Inc
|
1,428 | $517,107 | |
| 8 | GILD |
Gilead Sciences, Inc.
This page
|
2,504 | $316,355 |
All Filings in GILD
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $316,355 | 2,504 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $334,488 | 2,400 | Shares | Sole | 2026-05-27 | |
| 2025-12-31 | $280,829 | 2,288 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $240,759 | 2,169 | Shares | Sole | 2025-10-27 | |
| 2025-06-30 | $220,076 | 1,985 | Shares | Sole | 2025-08-12 | |
| 2021-06-30 | $207,062 | 3,007 | Shares | Sole | 2021-07-20 | |
| 2021-03-31 | $576,176 | 8,915 | Shares | Sole | 2021-04-29 | |
| 2020-12-31 | $439,105 | 7,537 | Shares | Sole | 2021-01-19 | |
| 2020-09-30 | $599,357 | 9,485 | Shares | Sole | 2020-10-20 | |
| 2020-06-30 | $648,911 | 8,434 | Shares | Sole | 2020-08-05 | |
| No filing history on record for this holder in this stock. | ||||||